ozmanjusri writes "Scientists at Sydney's Garvan Institute have identified an enzyme called PKCepsilon as the active agent that blocks the production of insulin in diabetics. Insulin injections and implants try to control levels but do not address the reasons why insulin production is failing. This discovery may allow pharmaceutical companies to develop a drug to block the enzyme, allowing cells in the pancreas to function normally, though the team's leader, Trevor Biden, says 'What we've identified is a target that we can now latch onto to get therapy, but the journey from target to tablet of course is a long one ... It's probably going to take another 10 years at least to get something that's effective in humans.'"
#NetNeutrality is STILL in danger - Click here to help. DEAL: For $25 - Add A Second Phone Number To Your Smartphone for life! Use promo code SLASHDOT25. Check out the new SourceForge HTML5 Internet speed test. ×